Search company, investor...

Biosynthesis Pharma Group

Submit Your Analyst Briefing

Stage

Acquired | Acquired

Valuation

$0000 

About Biosynthesis Pharma Group

Biosynthesis Pharma Group (BSPG) is an industry producer of industrial hemp, it's derivatives and pharmaceutical compounds for use in the medicinal, nutraceutical, food and cosmetic industries. Through BSPG's industrial-sized, proprietary extraction methodologies, BSPG produces high-purity, bioactive cannabinoids that are used in pharmaceutical applications to benefit those suffering from a range of life-threatening and non-life-threatening illnesses. BSPG is currently conducting clinical trials involving its product through strategic partnerships around the globe.

Headquarters Location

Hong Kong

Missing: Biosynthesis Pharma Group's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Biosynthesis Pharma Group's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Biosynthesis Pharma Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biosynthesis Pharma Group is included in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Biosynthesis Pharma Group News

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

Dec 27, 2017

Announces Binding Agreement to Acquire Biosynthesis Pharma Group December 17, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL ) (OTC: ISOL F) (FSE: LB6A.F ) (the â€œCompany” or “Isodiol”),a global Bioactive Phytoceutical innovator specializing in thedevelopment of pharmaceutical and wellness products, is pleased toannounce that the Company has entered into a binding agreement toacquire the Biosynthesis Pharma Group (BSPG), an industry leadingproducer of industrial hemp, it’s derivatives and pharmaceuticalcompounds for use in the medicinal, nutraceutical, food, and cosmeticindustries. Through BSPG’s industrial-sized, proprietary extractionmethodologies, BSPG produces high-purity, bioactive...... Some portions of the website are accessible only to members registered.

Biosynthesis Pharma Group Frequently Asked Questions (FAQ)

  • What is Biosynthesis Pharma Group's latest funding round?

    Biosynthesis Pharma Group's latest funding round is Acquired.

  • Who are the investors of Biosynthesis Pharma Group?

    Investors of Biosynthesis Pharma Group include Isodiol International.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.